Navigation Links
Amarantus Biosciences and RBCC Outline Terms for NuroPro Parkinson's Blood Test Joint Venture
Date:11/9/2012

NOKOMIS, Fla., and SUNNYVALE, Calif., Nov. 9, 2012 /PRNewswire/ -- Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp. (OTCBB: RBCC), and Amarantus BioSciences, Inc. (OTCQB: AMBS), a biotechnology company developing new disease-modifying treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury, have finalized the framework of their proposed joint venture (JV) and expect to execute material definitive agreements within 30 days, subject to closing documents.

The JV's first priority will be to advance Amarantus' NuroPro Parkinson's Diagnostic Blood Test ("NuroPro") towards commercialization. NuroPro works by identifying differentiated levels of proteins and peptides in the blood of patients who have Parkinson's disease, versus those who do not.

Under the terms of the pending agreement, RBCC will invest $150,000 over a 6 month period in various funding tranches to re-establish the NuroPro 2D Gel platform and re-analyze samples from the previous Phase 1 clinical trial. Thereafter, the JV will further fund the Phase 2 clinical trial. RBCC will be repaid for their investment out of proceeds from the sales generated by NuroPro and will share revenues once the initial investment is repaid. RBCC has received a commitment from private, outside sources to provide the capital necessary to fund the JV.

NuroPro has completed a Phase 1 human clinical trial, and the JV will initiate a Phase 2 clinical study upon successfully repeating the Phase 1 trial. Upon completing Phase 2, RBCC and Amarantus expect NuroPro to begin generating revenue through sales under a Clinical Laboratory Improvement Amendment (CLIA) certification.

"We've identified valuable upside in NuroPro, and we expect this project to begin paying for itself within a relatively short period of time," said Amarantus President & CEO Gerald Commissiong. "The ability to advance NuroPro in a manner that will simultaneously generate revenue while bol
'/>"/>

SOURCE Amarantus BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
2. Amarantus BioSciences Announces MANF Demonstrates Superiority over GDNF in Neurorestoration Behavioural Animal Model of Parkinsons Disease
3. Amarantus BioSciences Appoints Amgen Co-Founder Dr. Joseph Rubinfeld to Advisory Board
4. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
5. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
6. Neurocrine Biosciences Reports First Quarter 2012 Results
7. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
8. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
9. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
10. 3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference
11. Sofie Biosciences receives $1M Phase II SBIR grant from the DOE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... Israel , July 21, 2014 Galmed ... clinical-stage biopharmaceutical company focused on the development and commercialization ... liver diseases and cholesterol gallstones, announced today that it ... July 25, 2014 to discuss results for the period ... on current developments with respect to its clinical program ...
(Date:7/21/2014)... 2014   Aventura , the leader for ... today that MemorialCare Health System , a ... solution at the Orange Coast Memorial Medical ... Orange Coast Memorial is a 218-bed general ... patients annually. The Aventura Roaming Aware Desktop (RAD) ...
(Date:7/21/2014)... 21, 2014  A new Journal of the ... and scheduled to appear in the August 13 print ... new Hepatitis C Virus (HCV) treatments such as Sovaldi ... CVS Caremark (NYSE: CVS ) Chief Medical ... William Shrank , M.D., suggest that the discussion ...
Breaking Medicine Technology:Galmed Pharmaceuticals Second Quarter 2014 Conference Call and Webcast Scheduled for Friday, July 25, 2014 2MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 2MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 3MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 4CVS Caremark JAMA Commentary: New Hepatitis C Treatments Highlight Need to Control Costs of High-Priced Specialty Medications 2CVS Caremark JAMA Commentary: New Hepatitis C Treatments Highlight Need to Control Costs of High-Priced Specialty Medications 3
(Date:7/22/2014)... With over 170,000 students now playing high school ... during practice and competition, according to a new study ... Center for Injury Research and Policy at Nationwide Children,s ... today by The American Journal of Sports Medicine ... injuries over the four academic years from 2008 through ...
(Date:7/22/2014)... 2014 Garland’s new Energizer BK ... be used as a flood coat over new and ... a premium restoration material. It provides natural resistance to ... and reducing life-cycle costs. Energizer BK is specially formulated ... water resistance in addition to superior strength and flexibility. ...
(Date:7/22/2014)... CareTouch Communications, Inc. has formed a new ... . CareTouch employees will select causes they are passionate ... line with their mission to help people in and ... cause is Hike for Hospice, to benefit the Butterfly ... 14, the CareTouch in the Community team will climb ...
(Date:7/22/2014)... 2014 Most people encounter the same two problems ... and the second is a fast metabolism. These are hard problems ... provides ways to help fight these problems and to finally gain ... people out there who just can’t seem to eat more than ... are full. The cause of this problem can vary. For some ...
(Date:7/22/2014)... 22, 2014 A new and technologically ... laxity with results that are surprising even the most ... the skin with radio frequency, ThermiTight has been dubbed ... under the skin to “inject” heat to the tissues ... this single treatment solution for skin laxity produces results ...
Breaking Medicine News(10 mins):Health News:High school lacrosse players at risk of concussions other injuries 2Health News:High school lacrosse players at risk of concussions other injuries 3Health News:Energizer® BK Waterproof Coating from Garland Canada Reduces Life-Cycle Costs 2Health News:CareTouch is a Peak Sponsor for the 9th Annual Hike for Hospice in Morrison, Colorado 2Health News:CB-1 Weight Gainer Provides Two Tips to Help Customers Gain Weight 2Health News:New Minimally Invasive Procedure, ThermiTight, “Injects” Radio Frequency to Treat Skin Laxity 2
... report by the public services watchdog, the hospitals in Scotland ... with potentially// fatal condition known as ‘Deep vein thrombosis’ (DVT), ... the leg. ,An enquiry that was conducted in ... DVT, found that the failure to diagnose the condition had ...
... other form of treatment. But to a benefit of all GPs ... ,A resident artist much like resident doctors has been ... Susan Grant, a graduate of the Edinburgh School of Art. ... Council. ,It is one of 27 projects across Scotland ...
... It’s all wired at birth. Even the sex drive, researchers say. ... work to cure 'sex addicts'// , for the answer lies in ... more driven than others in seeking carnal pleasures. ,We ... University of the Negev in Israel. ,The scientists say ...
... bird flu in humans, a senior doctor in Moscow has ... but avian influenza in birds has claimed around 1.1 million ... have started tests on 120 volunteers," said Vitaly Zverev, the ... are mainly medical staff, doctors and donors. They are all ...
... plan to expand joint research into oral and throat ... ,The cooperation between Singapore's National Cancer Centre (NCC) and ... programme credited with cutting the death rate from mouth ... percent. ,The new joint effort, signed Monday, ...
... was found that people who were in their sixties have ... in an increase in the rates of cosmetic surgery. The ... among the procedures used in these surgeries. Statistics show ... of men and women in their sixties having cosmetic surgery ...
Cached Medicine News:Health News:Hospitals In Scotland Not Diagnosing DVT Properly 2
Compact, bench-top analyser with minimal water volume requirements and easy waste management....
Compact benchtop clinical chemistry system...
... 350 Chemistry System offers easy operation, maintenance, and ... STAT, or back-up to the powerful VITROS 5,1 ... the job done right the first time. Its ... are efficient, dependable, and easy-to-use. The VITROS 350 ...
Meet Galileo, the best reason to move to automation; the best way to upgrade your capabilities....
Medicine Products: